L. Winston

发表

Burden of Clostridium difficile Infection in the United States

Lisa G Winston, Yi Mu, J. Meek, 2015 .

Burden of Clostridium difficile infection in the United States.

J. Meek, D. Gerding, S. Fridkin, 2015, The New England journal of medicine.

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

D. Gerding, J. Edwards, W. Bamberg, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

D. Gerding, W. Bamberg, Z. Beldavs, 2013, JAMA internal medicine.

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations

J. Meek, S. Fridkin, Z. Beldavs, 2014, Open forum infectious diseases.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

D. Gerding, Z. Beldavs, G. Dumyati, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Novel handwashes are superior to soap and water in removal of Clostridium difficile spores from the hands.

L. Winston, B. Haller, Dylan S Isaacson, 2015, American journal of infection control.

Clinical, epidemiologic, and molecular evaluation of a clonal outbreak of methicillin-resistant Staphylococcus aureus infection.

Lisa G Winston, L. Winston, F. Perdreau-Remington, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penicillin-nonsusceptible Streptococcus pneumoniae at San Francisco General Hospital.

J. Gerberding, L. Winston, J. Perlman, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection

Raymund B. Dantes, J. Meek, W. Bamberg, 2015, Open forum infectious diseases.

Impact of a Piperacillin‐Tazobactam Shortage on Antimicrobial Prescribing and the Rate of Vancomycin‐Resistant Enterococci and Clostridium difficile Infections

C. McCulloch, B. Guglielmo, C. McCulloch, 2006, Pharmacotherapy.

Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.

D. Moore, Jonathan Z. Li, L. Winston, 2007, The American journal of medicine.

Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement.

A. Bolger, L. Winston, V. Jain, 2008, The Journal of infection.

Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis

A. Bolger, L. Winston, 2006, Current cardiology reports.

Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital.

J. Gerberding, D. Bangsberg, L. Winston, 2002, American journal of infection control.

Does doxycycline protect against development of Clostridium difficile infection?

L. Winston, H. Chambers, S. Doernberg, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Critical Evaluation of Healthcare-Associated Pneumonia and the Need for Anti-pseudomonal Therapy, Including Double Coverage

L. Winston, Rita Nguyen, 2014, Current Emergency and Hospital Medicine Reports.

A case of a rapid drop in lactate.

A. Wu, L. Winston, D. French, 2011, The American journal of emergency medicine.

Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013–2015

Corinne M. Davis, D. Gerding, Z. Beldavs, 2019, Journal of General Internal Medicine.

Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive S. aureus Infections: Opportunities for Improvement.

N. Hills, L. Winston, P. Coffin, 2021, The American journal of medicine.

Predictors of pneumonia severity in HIV-infected adults admitted to an Urban public hospital.

Jonathan Z. Li, L. Winston, I. Yen, 2011, AIDS patient care and STDs.

Introduction of a Waterless Hand Gel Was Associated With a Reduced Rate of Ventilator-Associated Pneumonia in a Surgical Intensive Care Unit

L. Winston, Wei-Hsiang Huang, H. Chambers, 2004, Infection Control & Hospital Epidemiology.

Mupirocin Prophylaxis Misses by a Nose

L. Winston, H. Chambers, 2004, Annals of Internal Medicine.

Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

D. Gerding, Z. Beldavs, G. Dumyati, 2020, The New England journal of medicine.

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study

D. Gerding, W. Bamberg, Z. Beldavs, 2015, Open forum infectious diseases.

Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 6: Prevention of Healthcare–Associated Infections)

Sumant R Ranji, Kanaka Shetty, Vandana Sundaram, 2007 .

Coming home with MRSA.

L. Winston, H. Chambers, 2009, Archives of internal medicine.

Mind the Base Rate: an Exercise in Clinical Reasoning

M. Henderson, L. Winston, P. Aronowitz, 2019, Journal of General Internal Medicine.

The Evolution of a Hospital-Based Covid-19 Vaccination Program for Inpatients

G. M. Ortiz, L. Winston, Dana Freiser, 2022, Nejm Catalyst Innovations in Care Delivery.

Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli in an urban county hospital.

L. Winston, S. Doernberg, 2012, American journal of infection control.

API 20 strep identification system may incorrectly speciate enterococci with low level resistance to vancomycin.

L. Winston, H. Chambers, F. Perdreau-Remington, 2004, Diagnostic microbiology and infectious disease.

Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections.

L. Winston, J. Dombrowski, Julia C. Dombrowski, 2008, The Journal of infection.

Comparative one-year outcomes of invasive Staphylococcus aureus infections among persons with and without drug use: an observational cohort study.

N. Hills, L. Winston, P. Coffin, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia

V. Fowler, R. Talwani, J. Baddley, 2006, Antimicrobial Agents and Chemotherapy.

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes

J. Meek, D. Gerding, Z. Beldavs, 2016, Open forum infectious diseases.

Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection with Greater Severity and Higher Recurrence Rates.

D. Gerding, G. Dumyati, M. Kainer, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association between Socioeconomic Status and Incidence of Community-Associated Clostridioides difficile Infection - United States, 2014-2015.

J. Meek, S. Fridkin, Z. Beldavs, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital

D. Schillinger, M. Handley, A. Cattamanchi, 2018, JAMA internal medicine.

Examining the association between hospital-onset Clostridium difficile infection and multiple-bed room exposure: a case-control study

L. Winston, A. Vaisman, Michael Jula, 2018, Infection Control & Hospital Epidemiology.

Clostridium difficile Infection Among Children Across Diverse US Geographic Locations

J. Meek, D. Gerding, Z. Beldavs, 2014, Pediatrics.

Antimicrobial Resistance in Staphylococci: Mechanisms of Resistance and Clinical Implications

L. Winston, H. Chambers, 2009 .

Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci.

D. Bangsberg, L. Winston, E. Charlebois, 2004, American journal of infection control.

Preoperative Use of Mupirocin for the Prevention of Healthcare-Associated Staphylococcus aureus Infections: A Cost-Effectiveness Analysis

L. Winston, L. Young, 2006, Infection Control & Hospital Epidemiology.

Trends in incidence of long‐term‐care facility onset Clostridium difficile infections in 10 US geographic locations during 2011‐2015

D. Gerding, W. Bamberg, Z. Beldavs, 2018, American journal of infection control.

Once-daily dosing of aminoglycosides: how much monitoring is truly required?

N. Benowitz, L. Winston, 2003, The American journal of medicine.

1665. Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test

D. Gerding, S. Fridkin, L. Winston, 2022, Open Forum Infectious Diseases.

Burden of Clostridium difficile infection in the United States.

F. Lessa, L. McDonald, M. Bouwknegt, 2015, The New England journal of medicine.

False-Positive Culture Results from Patient Tissue Specimens Due to Contamination of RPMI Medium with Cryptococcus albidus

L. Winston, M. Roemer, C. Goodman, 2007, Journal of Clinical Microbiology.

Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia.

L. Winston, Darcy Wooten, 2013, Respiratory medicine.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

D. Gerding, Z. Beldavs, G. Dumyati, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Burden of Clostridium difficile infection in the United States.

J. Meek, D. Gerding, S. Fridkin, 2015, The New England journal of medicine.

Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 6: Prevention of Healthcare–Associated Infections)

Kanaka D. Shetty, Robyn Lewis, L. Winston, 2007 .